Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani
Chairman, Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual reportThe business, the people and the ownership behind IHH.
Business overview
IHH Healthcare operates hospitals and healthcare services across international markets, including Singapore, Malaysia, India, Greater China, Türkiye and Europe. Its group interests also include laboratories and Parkway Life REIT.
Listed security
Board & management
Board profiles disclose11current directors and2alternate directors as at31March2026. Lim Tsin-Lin resigned on17September2025 and is retained separately as a former director.
CEO,CFO and country leadership roles are distinguished. The76,000employee team figure is stated in the CEO profile; it is not presented as audited full-time year-end headcount.
Director names follow each source: board profile Christine Li Shuling and ownership register Li Shuling, Christine identify the same named alternate director, but the original source wording is retained.
Telephone and fax digits retain the exact source; whitespace is normalized for display.
Chairman, Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report26 June 2024
As disclosed in FY2025 annual reportIndependent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report4 April 2018
As disclosed in FY2025 annual reportIndependent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report1 January 2021
As disclosed in FY2025 annual reportIndependent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report1 January 2021
As disclosed in FY2025 annual reportIndependent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report14 August 2024
As disclosed in FY2025 annual reportIndependent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report17 September 2025
As disclosed in FY2025 annual reportNon-Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report1 April 2024
As disclosed in FY2025 annual reportNon-Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report3 February 2023
As disclosed in FY2025 annual reportNon-Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report29 March 2023
As disclosed in FY2025 annual reportNon-Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report24 January 2012
As disclosed in FY2025 annual reportNon-Independent, Non-Executive
Board profiles as at31March2026 in FY2025 annual report17 September 2025
As disclosed in FY2025 annual reportNon-Independent, Non-Executive; Alternate Director to Mohd Shahazwan bin Mohd Harris
Board profiles as at31March2026 in FY2025 annual report17 September 2025
As disclosed in FY2025 annual reportNon-Independent, Non-Executive; Alternate Director to Yoichiro Endo
Board profiles as at31March2026 in FY2025 annual report6 March 2025
As disclosed in FY2025 annual reportGroup Chief Executive Officer
As disclosed in FY2025 annual reportGroup Chief Financial Officer
As disclosed in FY2025 annual reportGroup Chief Corporate Officer
As disclosed in FY2025 annual reportGroup Chief Medical Officer
As disclosed in FY2025 annual reportGroup Chief Human Resource Officer
As disclosed in FY2025 annual reportGroup General Counsel
As disclosed in FY2025 annual reportGroup Chief Internal Audit Officer
As disclosed in FY2025 annual reportGroup Chief Risk Officer
As disclosed in FY2025 annual reportCompany Secretary
As disclosed in FY2025 annual reportChief Executive Officer, IHH Healthcare Malaysia
As disclosed in FY2025 annual reportChief Executive Officer, IHH Healthcare Singapore
As disclosed in FY2025 annual reportRegional Chief Executive Officer, IHH Healthcare North Asia
As disclosed in FY2025 annual reportManaging Director & Chief Executive Officer, Fortis Healthcare
As disclosed in FY2025 annual reportChief Executive Officer, Acibadem Sağlık Yatırımlar Holding A.S
As disclosed in FY2025 annual report76,000 employees — team size stated in the Group CEO profile; the source does not specify a full-time year-end headcount
As disclosed in FY2025 annual reportLevel 35, Mercu Aspire, 3 Jalan Bangsar, KL Eco City, 59200 Kuala Lumpur, Wilayah Persekutuan, Malaysia
Corporate information as at31March2026+603 2201 0138
Corporate information as at31March2026+603 2201 0148
Corporate information as at31March2026www.ihhhealthcare.com
Corporate information as at31March2026KPMG PLT — Chartered Accountants
Corporate information as at31March2026Level 10, KPMG Tower, 8 First Avenue, Bandar Utama, 47800 Petaling Jaya, Selangor Darul Ehsan, Malaysia
Corporate information as at31March2026Boardroom Share Registrars Sdn Bhd; 11th Floor, Menara Symphony, No. 5 Jalan Prof. Khoo Kay Kim, Seksyen 13, 46200 Petaling Jaya, Selangor Darul Ehsan, Malaysia
Corporate information as at31March2026Boardroom Corporate & Advisory Services Pte Ltd; 1 Harbourfront Avenue, #14-07 Keppel Bay Tower, Singapore 098632
Corporate information as at31March2026Resigned on17September2025; excluded from current board count
Corporate information as at31March2026Roles listed in IHH Healthcare Berhad Annual Report 2025; current appointments are not independently verified.
Holdings
Top30 registered row27 prints0.22%, while18,992,184shares divided by8,836,153,463rounds0.21%; the original percentage is retained.
Register date31March2026 differs from financial year end31December2025. Registered nominee blocks and substantial direct/indirect interests are separate disclosures and are not added together.
Employees Provident Fund Board substantial holding is explicitly held through various nominee companies; only nominee beneficiaries explicitly named in the top30 register are displayed. No beneficial owner is inferred for exempt accounts.
Directors’ and Group CEO’s company shareholdings retain the original register names; separate subsidiary shareholdings use subsidiary share capital and are not IHH shares.
7,565,119,759 shares (85.62%)
As at31March2026Direct: 2,888,487,400 shares (32.69%); indirect: 0 shares (0.00%)
As at31March2026Direct: 0 shares (0.00%); indirect: 2,888,487,400 shares (32.69%)
As at31March2026Direct: 2,284,536,356 shares (25.85%); indirect: 0 shares (0.00%)
As at31March2026Direct: 0 shares (0.00%); indirect: 2,284,536,356 shares (25.85%)
As at31March2026Direct: 1,140,645,100 shares (12.91%); indirect: 0 shares (0.00%)
As at31March2026Direct: 7,948,000 shares (0.09%); indirect: 507,221,573 shares (5.74%)
As at31March2026Direct: 7,000,000 shares (0.08%); indirect: 500,221,573 shares (5.66%)
As at31March2026Direct: 500,221,573 shares (5.66%); indirect: 0 shares (0.00%)
As at31March2026Holders: 481 (6.08%); shares: 4,975 (0.00%)
As at31March2026Holders: 2,808 (35.48%); shares: 1,740,692 (0.02%)
As at31March2026Holders: 2,801 (35.39%); shares: 11,955,000 (0.14%)
As at31March2026Holders: 975 (12.32%); shares: 33,906,830 (0.38%)
As at31March2026Holders: 846 (10.69%); shares: 2,839,939,000 (32.14%)
As at31March2026Holders: 3 (0.04%); shares: 5,948,606,966 (67.32%)
As at31March2026Holders: 7,914 (100.00%); shares: 8,836,153,463 (100.00%)
As at31March2026Holders: 4,923 (62.21%); shares: 22,794,764 (0.26%)
As at31March2026Holders: 83 (1.05%); shares: 555,943,118 (6.29%)
As at31March2026Holders: 4 (0.05%); shares: 139,000 (0.00%)
As at31March2026Holders: 117 (1.48%); shares: 5,173,190,776 (58.55%)
As at31March2026Holders: 1 (0.01%); shares: 65,000 (0.00%)
As at31March2026Holders: 2,785 (35.19%); shares: 3,084,020,803 (34.90%)
As at31March2026Holders: 1 (0.01%); shares: 2 (0.00%)
As at31March2026Holders: 7,914 (100.00%); shares: 8,836,153,463 (100.00%)
As at31March20268,836,153,463 ordinary shares
As at31March2026One vote per ordinary share
As at31March2026Direct: 7,948,000 shares (0.09%); indirect: 507,221,573 shares (5.74%)
As at31March2026Direct: 10,000 shares (0.00%); indirect: 0 shares (0.00%)
As at31March2026Direct: 778,000 shares (0.01%); indirect: 0 shares (0.00%)
As at31March2026Direct: 217,211,842 shares (9.28%); indirect: 16,828,159 shares (0.72%); share class: TL1.00 ordinary shares
As at31March2026Direct: 1 shares (0.00%); indirect: 1 shares (0.00%); share class: TL1.00 ordinary shares
As at31March2026Direct: 1 shares (0.00%); indirect: 0 shares (0.00%); share class: TL1.00 ordinary shares
As at31March2026Direct: 1 shares (0.00%); indirect: 2 shares (0.00%); share class: TL1.00 ordinary shares
As at31March2026Direct: 1 shares (0.00%); indirect: 1 shares (0.00%); share class: TL2.00 ordinary shares
As at31March2026Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership.
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| MBK Healthcare Management Pte Ltd | 2,888,487,400 shares (32.69%) | PDF p. 79 | |
| Pulau Memutik Ventures Sdn Bhd | 2,266,086,176 shares (25.65%) | PDF p. 79 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board | 794,033,390 shares (8.99%) | PDF p. 79 | |
| Citigroup Nominees (Asing) Sdn Bhd UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi | 292,601,573 shares (3.31%) | PDF p. 79 | |
| Kumpulan Wang Persaraan (Diperbadankan) | 243,087,500 shares (2.75%) | PDF p. 79 | |
| Citigroup Nominees (Asing) Sdn Bhd Exempt AN for the Central Depository (Pte) Limited | 233,875,565 shares (2.65%) | PDF p. 79 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (Islamic) | 199,071,710 shares (2.25%) | PDF p. 79 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Exempt AN for AIA Bhd | 54,122,800 shares (0.61%) | PDF p. 79 | |
| Lembaga Tabung Haji | 47,089,500 shares (0.53%) | PDF p. 79 | |
| HSBC Nominees (Asing) Sdn Bhd JPMCB NA for Vanguard Total International Stock Index Fund | 45,125,602 shares (0.51%) | PDF p. 79 | |
| HSBC Nominees (Asing) Sdn Bhd JPMCB NA for Vanguard Emerging Markets Stock Index Fund | 42,556,035 shares (0.48%) | PDF p. 79 | |
| HSBC Nominees (Asing) Sdn Bhd Exempt AN for Morgan Stanley & Co. International PLC (IPB CLIENT ACCT) | 41,329,600 shares (0.47%) | PDF p. 79 | |
| Maybank Nominees (Tempatan) Sdn Bhd Maybank Trustees Berhad for Public Ittikal Fund (N14011970240) | 41,000,000 shares (0.46%) | PDF p. 79 | |
| Amanahraya Trustees Berhad Amanah Saham Bumiputera | 32,269,100 shares (0.37%) | PDF p. 79 | |
| Amanahraya Trustees Berhad Amanah Saham Malaysia 3 | 28,566,500 shares (0.32%) | PDF p. 79 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (AHAM AM) | 26,568,400 shares (0.30%) | PDF p. 80 | |
| Cartaban Nominees (Tempatan) Sdn Bhd Prudential Assurance Malaysia Berhad for Prulink Strategic Fund | 26,010,700 shares (0.29%) | PDF p. 80 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Great Eastern Life Assurance (Malaysia) Berhad (PAR 1) | 24,397,700 shares (0.28%) | PDF p. 80 | |
| Permodalan Nasional Berhad | 23,725,300 shares (0.27%) | PDF p. 80 | |
| HSBC Nominees (Asing) Sdn Bhd JPMCB NA for Vanguard Fiduciary Trust Company Institutional Total International Stock Market Index Trust II | 22,580,024 shares (0.26%) | PDF p. 80 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (Nomura) | 20,722,900 shares (0.23%) | PDF p. 80 | |
| Amanahraya Trustees Berhad Public Ittikal Sequel Fund | 20,602,200 shares (0.23%) | PDF p. 80 | |
| Amanahraya Trustees Berhad Public Islamic Dividend Fund | 20,462,900 shares (0.23%) | PDF p. 80 | |
| Cartaban Nominees (Tempatan) Sdn Bhd PBTB for Takafulink Dana Ekuiti | 19,985,200 shares (0.23%) | PDF p. 80 | |
| Cartaban Nominees (Tempatan) Sdn Bhd PAMB for Prulink Equity Fund | 19,538,500 shares (0.22%) | PDF p. 80 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (AsianIslamic) | 19,398,600 shares (0.22%) | PDF p. 80 | |
| Citigroup Nominees (Asing) Sdn Bhd CBNY for Ishares Core MSCI Emerging Markets ETF | 18,992,184 shares (0.22%) | PDF p. 80 | |
| Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (CGS CIMB) | 17,672,200 shares (0.20%) | PDF p. 80 | |
| HSBC Nominees (Asing) Sdn Bhd HSBC-FS G for People's Bank of China (SICL ASIA EM) | 17,660,500 shares (0.20%) | PDF p. 80 | |
| Maybank Nominees (Tempatan) Sdn Bhd Maybank Trustees Berhad for Public Regular Savings Fund (N14011940100) | 17,500,000 shares (0.20%) | PDF p. 80 | |
Group structure
The complete Note38–40 entity lists are retained on their source classifications, including subsidiaries with effective interests below50%, dissolved entities and joint ventures above50%. Percentages alone do not determine control.
The table heading is effective ownership interest and voting interest; FY2025 and FY2024 percentages are retained as printed and are not presented as direct stakes in each subsidiary.
Held-through parent headings are retained with their original source pages. IHH Financial Services and Parkway Vietnam Holdings appear on separate former/current parent rows following disclosed intra-group transfers; the rows are not silently deduplicated.
A dash in FY2025 remains the source dash for transferred, dissolved or liquidated entities; no numeric zero is fabricated. Note38 footnotes explain mixed direct holding percentages and consolidation of special-purpose entities.
| Company | Market | Ownership interest |
|---|---|---|
| Integrated Healthcare Holdings LimitedSubsidiary — Note38PDF p. 66 | Country: Federal Territory of Labuan Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Company. | |
| Integrated Healthcare Turkey Yatirimlari LimitedSubsidiary — Note38PDF p. 66 | Country: Federal Territory of Labuan Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Company. | |
| IHH Financial Services Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: – / 100%; principal activity: Treasury centre; held through Company. | |
| IHH Laboratories Holdings Sdn. Bhd.Subsidiary — Note38PDF p. 66 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Company. | |
| Parkway Pantai LimitedSubsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Integrated Healthcare Holdings Limited. | |
| Integrated Healthcare Hastaneler Turkey Sdn. Bhd.Subsidiary — Note38PDF p. 66 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Integrated Healthcare Turkey Yatirimlari Limited. | |
| IHH Laboratories Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and provision of services for medical diagnostic laboratory tests; held through IHH Laboratories Holdings Sdn. Bhd.. | |
| Pantai Holdings Sdn. Bhd.Subsidiary — Note38PDF p. 66 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited. | |
| Parkway Holdings LimitedSubsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited. | |
| IHH Financial Services Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / –; principal activity: Treasury centre; held through Parkway Pantai Limited. | |
| Parkway Healthcare Indo-China Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited. | |
| Parkway Group Healthcare Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and provision of technical support services; held through Parkway Pantai Limited. | |
| Parkway HK Holdings LimitedSubsidiary — Note38PDF p. 66 | Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited. | |
| Gleneagles Development Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited. | |
| Northern TK Venture Pte. Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited. | |
| Acibadem Saglik Yatirımlari Holding A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 90.00% / 90.00%; principal activity: Investment holding; held through Integrated Healthcare Hastaneler Turkey Sdn. Bhd.. | |
| Parkway Laboratory Services Ltd.Subsidiary — Note38PDF p. 66 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of comprehensive diagnostic laboratory services; held through IHH Laboratories Pte. Ltd.. | |
| Premier Integrated Labs Sdn. Bhd.Subsidiary — Note38PDF p. 66 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical laboratory services; held through IHH Laboratories Pte. Ltd.. | |
| Orifolio Options Sdn. Bhd.Subsidiary — Note38PDF p. 66 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Letting of property; held through Premier Integrated Labs Sdn. Bhd.. | |
| APlus Hastane Otelcilik Hizmetleri A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.99% / 89.99%; principal activity: Provision of catering, laundry and cleaning services for hospitals; held through Acibadem Saglik Yatirımlari Holding A.S.. | |
| Acibadem Proje Yonetimi A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.99% / 89.99%; principal activity: Supervise and manage the construction of healthcare facilities; held through Acibadem Saglik Yatirımlari Holding A.S.. | |
| Acibadem Saglik Hizmetleri ve Ticaret A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem Saglik Yatirımlari Holding A.S.. | |
| Acibadem Poliklinikleri A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of outpatient and surgical (in certain clinics only) services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Acibadem Labmed Saglik Hizmetleri A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of laboratory services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| International Hospital İstanbul A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 80.81% / 80.81%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Acibadem Mobil Saglik Hizmetleri A.S.Subsidiary — Note38PDF p. 66 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of emergency, home and ambulatory care services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Clinical Hospital Acibadem Sistina SkopjeSubsidiary — Note38PDF p. 66 | Country: Macedonia; effective ownership and voting interest FY2025/FY2024: 48.33% / 48.33%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Acibadem International Medical Center B.V.Subsidiary — Note38PDF p. 66 | Country: Netherlands; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of outpatient services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Acibadem Teknoloji A.S.Subsidiary — Note38PDF p. 67 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Conduct research, develop and commercially market healthcare information systems, web-based applications and other technology solutions nationally and internationally; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Acibadem City Clinic B.V.Subsidiary — Note38PDF p. 67 | Country: Netherlands; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Investment holding; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| LifeClub Saglikli Yasam Hizmetleri A.S.Subsidiary — Note38PDF p. 67 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of e-consulting activities, wellness services and marketplace activities relating to all health-related products and memberships to its subscribers; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Bayek Tedavi Saglik Hizmetleri ve Isletmeciligi Anonim SirketiSubsidiary — Note38PDF p. 67 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 71.83% / –; principal activity: Provision of healthcare services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S.. | |
| Penta Tip Saglik Hizmetleri Anonim SirketiSubsidiary — Note38PDF p. 67 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 71.83% / –; principal activity: Provision of healthcare services; held through Bayek Tedavi Saglik Hizmetleri ve Isletmeciligi Anonim Sirketi. | |
| Bayek Agiz ve Dis Sagligi Hizmetleri ve Isletmeciligi Anonim SirketiSubsidiary — Note38PDF p. 67 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 71.83% / –; principal activity: Provision of dentalcare services; held through Bayek Tedavi Saglik Hizmetleri ve Isletmeciligi Anonim Sirketi. | |
| Bodrum Medikal Saglik Hizmetleri A.S.Subsidiary — Note38PDF p. 67 | Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 53.88% / 53.88%; principal activity: Provision of outpatient services; held through Acibadem Poliklinikleri A.S.. | |
| Acibadem Sistina Medikal Kompani Doo SkopjeSubsidiary — Note38PDF p. 67 | Country: Macedonia; effective ownership and voting interest FY2025/FY2024: 48.33% / 48.33%; principal activity: Provision of medical equipment and import and wholesale of drug and medical materials; held through Clinical Hospital Acibadem Sistina Skopje. | |
| General Hospital Acibadem Bel MedicSubsidiary — Note38PDF p. 67 | Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem City Clinic B.V.. | |
| Acibadem City Clinic EADSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Investment holding; held through Acibadem City Clinic B.V.. | |
| Health Centre Acibadem Bel MedicSubsidiary — Note38PDF p. 67 | Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of medical and general surgical services; held through General Hospital Acibadem Bel Medic. | |
| Bel Food & Coffee d.o.oSubsidiary — Note38PDF p. 67 | Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of services of preparation and serving food; held through General Hospital Acibadem Bel Medic. | |
| Acibadem Bel Medic Logistics D.O.O BeogradSubsidiary — Note38PDF p. 67 | Country: Serbia; effective ownership and voting interest FY2025/FY2024: – / 71.13%; principal activity: Liquidated during the year; held through General Hospital Acibadem Bel Medic. | |
| Health Centre Acibadem Bel Medic SlavijaSubsidiary — Note38PDF p. 67 | Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of medical services; held through Health Centre Acibadem Bel Medic. | |
| Acibadem City Clinic University Hospital EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: University multi-profile hospital for acute care; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Diagnostic and Consultation Centre EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Outpatient diagnostic and consultative centre; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Medical Center Varna EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Outpatient medical centre; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Assistance EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Facility management and building maintenance; held through Acibadem City Clinic EAD. | |
| Healthcare Consulting EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Clinical research; held through Acibadem City Clinic EAD. | |
| Tokuda Clinical Research Center ADSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 60.46% / 60.46%; principal activity: Clinical research; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Services EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Facility management and building maintenance; held through Acibadem City Clinic EAD. | |
| Tokuda Pharmacy EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Pharmacy; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Diagnostic and Consultation Center Tokuda EADSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Outpatient diagnostic and consultative centre; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Tokuda University Hospital EADSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Multi-profile hospital for acute care; held through Acibadem City Clinic EAD. | |
| Acibadem City Clinic Mladost EOODSubsidiary — Note38PDF p. 67 | Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of construction, hospitality and trade-related services; held through Acibadem City Clinic EAD. | |
| Pantai Group Resources Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Pantai Holdings Sdn. Bhd.. | |
| Pantai Hospitals Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and provision of management and consultation services to hospitals and medical centres; held through Pantai Holdings Sdn. Bhd.. | |
| Pantai Management Resources Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Holdings Sdn. Bhd.. | |
| Gleneagles (Malaysia) Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Pantai Holdings Sdn. Bhd.. | |
| Prince Court Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Holdings Sdn. Bhd.. | |
| Bedrock Healthcare Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Pantai Holdings Sdn. Bhd.. | |
| Island Hospital Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Holdings Sdn. Bhd.. | |
| Premier Integrated Rehab Sdn. Bhd. (f.k.a. Pantai Integrated Rehab Services Sdn. Bhd.)Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of rehabilitation services; held through Pantai Group Resources Sdn. Bhd.. | |
| Pantai Wellness Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of health and wellness services; held through Pantai Group Resources Sdn. Bhd.. | |
| Twin Towers Medical Centre KLCC Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of an outpatient and daycare medical centre; held through Pantai Group Resources Sdn. Bhd.. | |
| Pantai Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services, as well as providing administrative support, management and consultancy services; held through Pantai Hospitals Sdn. Bhd.. | |
| Cheras Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Pantai Klang Specialist Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Syarikat Tunas Pantai Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd.. | |
| Paloh Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 95.60% / 95.60%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd.. | |
| Hospital Pantai Ayer Keroh Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Hospital Pantai Indah Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd.. | |
| Pantai Hospital Sungai Petani Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Pantai Screening Services Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Gleneagles Hospital (Kuala Lumpur) Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Pantai Hospital Manjung Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd.. | |
| Pantai Hospital Johor Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Development, construction and leasing of medical facility buildings; held through Pantai Hospitals Sdn. Bhd.. | |
| Amanjaya Specialist Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd.. | |
| Pulau Pinang Clinic Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 71.88% / 71.88%; principal activity: Provision of hospital services; held through Gleneagles (Malaysia) Sdn. Bhd.. | |
| GEH Management Services (M) Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Gleneagles (Malaysia) Sdn. Bhd.. | |
| Mestika Unik Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of a specialist medical centre; held through Bedrock Healthcare Sdn. Bhd.. | |
| Eminent Rock Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of a specialist medical centre; held through Mestika Unik Sdn. Bhd. | |
| Island Retail Pharmacy Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of retail sale of pharmaceutical, medical and orthopaedic goods; held through Island Hospital Sdn. Bhd.. | |
| Coronation Springs Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Property development; held through Island Hospital Sdn. Bhd.. | |
| IMC Hospitality Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of hospitality services; held through Island Hospital Sdn. Bhd.. | |
| Island Medisuite Sdn. Bhd.Subsidiary — Note38PDF p. 68 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Property development; held through Island Hospital Sdn. Bhd.. | |
| Pantai-ARC Dialysis Services Sdn. Bhd.Subsidiary — Note38PDF p. 69 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 51.00% / 51.00%; principal activity: Provision of haemodialysis services; held through Pantai Medical Centre Sdn. Bhd.. | |
| Oncology Centre (KL) Sdn. Bhd.Subsidiary — Note38PDF p. 69 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of comprehensive professional oncological services, inclusive of diagnostic, radiotherapy and chemotherapy treatment; held through Pantai Medical Centre Sdn. Bhd.. | |
| Parkway Hospitals Singapore Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Private hospitals ownership and management; held through Parkway Holdings Limited. | |
| Parkway Novena Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Development, ownership and management of private hospital premises; held through Parkway Holdings Limited. | |
| Parkway Irrawaddy Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Development, ownership and management of a medical centre; held through Parkway Holdings Limited. | |
| Parkway Shenton Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and operation of a network of clinics and provision of comprehensive medical and surgical advisory services; held through Parkway Holdings Limited. | |
| Medi-Rad Associates Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of radiology clinics; held through Parkway Holdings Limited. | |
| Gleneagles Medical Holdings LimitedSubsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Holdings Limited. | |
| Parkway College of Nursing and Allied Health Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of courses in nursing and allied health; held through Parkway Holdings Limited. | |
| iXchange Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Agent and administrator for managed care and related services; held through Parkway Holdings Limited. | |
| Parkway Vietnam Holdings Pte. Ltd. (f.k.a. Parkway Shenton International Holdings Pte. Ltd.)Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / –; principal activity: Investment holding; held through Parkway Holdings Limited. | |
| Gleneagles Management Services Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of advisory, administrative, management and consultancy services to healthcare facilities; held through Parkway Holdings Limited. | |
| Parkway Trust Management LimitedSubsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of management services to PLife REIT; held through Parkway Holdings Limited. | |
| Parkway Investments Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Holdings Limited. | |
| Parkway Promotions Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Parkway Hospitals Singapore Pte. Ltd.. | |
| Nippon Medical Care Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.00% / 70.00%; principal activity: Operation of clinics; held through Parkway Shenton Pte. Ltd.. | |
| Parkway Vietnam Holdings Pte. Ltd. (f.k.a. Parkway Shenton International Holdings Pte. Ltd.)Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: – / 100%; principal activity: Investment holding; held through Parkway Shenton Pte. Ltd.. | |
| Shenton Family Medical Clinics Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: To provide, establish and carry on the business of clinics; held through Parkway Shenton Pte. Ltd.. | |
| Radiology Consultants Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of radiology consultancy and interpretative services; held through Medi-Rad Associates Ltd.. | |
| Andaman Alliance Healthcare LimitedSubsidiary — Note38PDF p. 69 | Country: Myanmar; effective ownership and voting interest FY2025/FY2024: – / 52.00%; principal activity: Liquidated during the year; held through Parkway Healthcare Indo-China Pte. Ltd.. | |
| Parkway-Healthcare (Mauritius) Ltd.Subsidiary — Note38PDF p. 69 | Country: Mauritius; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Group Healthcare Pte. Ltd.. | |
| Gleneagles International Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Group Healthcare Pte. Ltd.. | |
| PCH Holding Pte. Ltd.Subsidiary — Note38PDF p. 69 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through Parkway Group Healthcare Pte. Ltd.. | |
| Shanghai Gleneagles Hospital Management Co., Ltd.Subsidiary — Note38PDF p. 69 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of management and consultancy services to healthcare facilities; held through Parkway Group Healthcare Pte. Ltd.. | |
| IHH Technology Sdn. Bhd.Subsidiary — Note38PDF p. 69 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of computer software designing development, customisation, integration, implementation, maintenance and related services; held through Parkway Group Healthcare Pte. Ltd.. | |
| Medical Resources International Pte. Ltd.Subsidiary — Note38PDF p. 70 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through PCH Holding Pte. Ltd.. | |
| Parkway (Shanghai) Hospital Management Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of management and consultancy services to healthcare facilities; held through PCH Holding Pte. Ltd.. | |
| M & P Investments Pte. Ltd.Subsidiary — Note38PDF p. 70 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through PCH Holding Pte. Ltd.. | |
| Shanghai Rui Xin Healthcare Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Medical Resources International Pte. Ltd.. | |
| Shanghai Rui Hong Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Medical Resources International Pte. Ltd.. | |
| Shanghai Xin Rui Healthcare Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Medical Resources International Pte. Ltd.. | |
| Shanghai Shu Kang Hospital Investment Management Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through Parkway (Shanghai) Hospital Management Ltd.. | |
| Suzhou Industrial Park Yuan Hui Health Consulting Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Parkway (Shanghai) Hospital Management Ltd.. | |
| Shanghai Mai Kang Hospital Investment Management Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through Shanghai Shu Kang Hospital Investment Management Co., Ltd.. | |
| Chengdu Rui Rong Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd.. | |
| Shanghai Rui Pu Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd.. | |
| Shanghai Rui Xiang Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd.. | |
| Shanghai Rui Ying Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd.. | |
| ParkwayHealth Shanghai Hospital Company LimitedSubsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 49.07% / 49.07%; principal activity: Provision of medical and health related facilities and services; held through M & P Investments Pte. Ltd.. | |
| Parkway Healthcare (Hong Kong) LimitedSubsidiary — Note38PDF p. 70 | Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical and healthcare outpatient services; held through Parkway HK Holdings Limited. | |
| GHK Hospital LimitedSubsidiary — Note38PDF p. 70 | Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 60.00% / 60.00%; principal activity: Private hospital ownership, development and management; held through Parkway HK Holdings Limited. | |
| Parkway Medical Services (Hong Kong) LimitedSubsidiary — Note38PDF p. 70 | Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 60.00% / 60.00%; principal activity: Provision of healthcare services; held through Parkway HK Holdings Limited. | |
| Gleneagles HK International Services (Shenzhen) Co., Ltd.Subsidiary — Note38PDF p. 70 | Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 60.00% / –; principal activity: Provision of medical concierge services, regional commercial development and marketing, and seeking partnership opportunities; held through Parkway Medical Services (Hong Kong) Limited. | |
| Parkway Healthcare India Private LimitedSubsidiary — Note38PDF p. 70 | Country: India; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of management and consultancy services; held through Gleneagles Development Pte. Ltd.. | |
| Gleneagles Healthcare India Pte. Ltd.Subsidiary — Note38PDF p. 70 | Country: India; effective ownership and voting interest FY2025/FY2024: 99.15% / 99.15%; principal activity: Private hospital ownership and management, specialty tertiary care including multi organ transplant healthcare facility; held through Gleneagles Development Pte. Ltd.. | |
| Centre for Digestive and Kidney Diseases (India) Private LimitedSubsidiary — Note38PDF p. 70 | Country: India; effective ownership and voting interest FY2025/FY2024: 64.43% / 64.43%; principal activity: Private hospital ownership and management, specialty tertiary care including multi organ transplant healthcare facility; held through Gleneagles Healthcare India Pte. Ltd.. | |
| Gleneagles Clinical Research Services (India) Private LimitedSubsidiary — Note38PDF p. 70 | Country: India; effective ownership and voting interest FY2025/FY2024: 99.15% / 99.15%; principal activity: Provision of clinical research services; held through Gleneagles Healthcare India Pte. Ltd.. | |
| Fortis Healthcare LimitedSubsidiary — Note38PDF p. 70 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates multi-specialty hospitals; held through Northern TK Venture Pte. Ltd.. | |
| Hiranandani Healthcare Private LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates a multi-specialty hospital; held through Fortis Healthcare Limited. | |
| Fortis Hospotel LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services; held through Fortis Healthcare Limited. | |
| Adayu Mindfulness LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Healthcare Limited. | |
| Fortis Healthcare International LimitedSubsidiary — Note38PDF p. 71 | Country: Mauritius; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Healthcare Limited. | |
| Agilus Diagnostics LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Fortis Healthcare Limited. | |
| Escorts Heart Institute and Research Centre LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates a multi-specialty hospital; held through Fortis Healthcare Limited. | |
| Fortis Hospitals LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates a network of multi-specialty hospitals; held through Fortis Healthcare Limited. | |
| Fortis CSR FoundationSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Non-profit company for carrying out corporate social responsibilities; held through Fortis Healthcare Limited. | |
| International Hospital LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services and operates a hospital; held through Fortis Healthcare Limited. | |
| Fortis Health Management LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services and operates a hospital; held through Fortis Healthcare Limited. | |
| Escorts Heart and Super Speciality Hospital LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services; held through Fortis Healthcare Limited. | |
| Artistery Properties Private LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Acquires, maintains, improves, develops, and manages land; held through Fortis Healthcare Limited. | |
| Hospitalia Eastern Private LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services; held through Fortis Health Management Limited. | |
| Agilus Pathlabs Private LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited. | |
| DDRC Agilus Pathlabs LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostic centres; held through Agilus Diagnostics Limited. | |
| Agilus Pathlabs Reach LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited. | |
| Agilus Diagnostics FZ-LLCSubsidiary — Note38PDF p. 71 | Country: United Arab Emirates; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited. | |
| Fortis Emergency Services LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates ambulance services; held through Fortis Hospitals Limited. | |
| Fortis Cancer Care LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Hospitals Limited. | |
| Fortis Malar Hospitals LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 19.57% / 19.55%; principal activity: Operates a multi-specialty hospital; held through Fortis Hospitals Limited. | |
| Fortis Health Management (East) LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Dormant; held through Fortis Hospitals Limited. | |
| Birdie & Birdie Realtors Private LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Dormant; held through Fortis Hospitals Limited. | |
| Stellant Capital Advisory Services Private LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Merchant banker; held through Fortis Hospitals Limited. | |
| Fortis Global Healthcare (Mauritius) LimitedSubsidiary — Note38PDF p. 71 | Country: Mauritius; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Hospitals Limited. | |
| Fortis Asia Healthcare Pte. Ltd.Subsidiary — Note38PDF p. 71 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Escorts Heart Institute and Research Centre Limited. | |
| Fortis Health-Staff LimitedSubsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Dormant; held through Escorts Heart Institute and Research Centre Limited. | |
| MENA Healthcare Investment Company LimitedSubsidiary — Note38PDF p. 71 | Country: British Virgin Islands; effective ownership and voting interest FY2025/FY2024: 25.73% / 25.73%; principal activity: Investment holding; held through Fortis Asia Healthcare Pte. Ltd.. | |
| Medical Management Company LimitedSubsidiary — Note38PDF p. 71 | Country: British Virgin Islands; effective ownership and voting interest FY2025/FY2024: 25.73% / 25.73%; principal activity: Investment holding; held through MENA Healthcare Investment Company Limited. | |
| Fortis Healthcare Research Foundation (f.k.a. Malar Stars Medicare Limited)Subsidiary — Note38PDF p. 71 | Country: India; effective ownership and voting interest FY2025/FY2024: 19.57% / 19.55%; principal activity: Investment holding; held through Fortis Malar Hospitals Limited. | |
| RHT Health Trust Manager Pte. LimitedSubsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Trustee-manager of a business trust; held through Stellant Capital Advisory Services Private Limited. | |
| Parkway Trust Management Japan K.K.Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 100% / –; principal activity: Provision of asset management services; held through Parkway Trust Management Limited. | |
| Gleneagles Medical Centre Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Parkway Investments Pte. Ltd.. | |
| Gleneagles Pharmacy Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Parkway Investments Pte. Ltd.. | |
| Mount Elizabeth Medical Holdings LimitedSubsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Investments Pte. Ltd.. | |
| Parkway Life Real Estate Investment TrustSubsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Real estate investment trust; held through Parkway Investments Pte. Ltd.. | |
| Parkway Life Japan2 Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust. | |
| Parkway Life Japan3 Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust. | |
| Parkway Life Japan4 Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust. | |
| Parkway Life MTN Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Provision of financial and treasury services; held through Parkway Life Real Estate Investment Trust. | |
| Parkway Life Malaysia Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust. | |
| Parkway Life Nova Pte. Ltd.Subsidiary — Note38PDF p. 72 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust. | |
| Godo Kaisha Del MonteSubsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd.. | |
| Godo Kaisha Tenshi 1Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd.. | |
| Godo Kaisha Tenshi 2Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd.. | |
| G.K. NestSubsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd.. | |
| Godo Kaisha Samurai 19Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd.. | |
| Godo Kaisha Samurai 20Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd.. | |
| Godo Kaisha Healthcare 1Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd.. | |
| Godo Kaisha Healthcare 2Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd.. | |
| Godo Kaisha Healthcare 3Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd.. | |
| Godo Kaisha Healthcare 4Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd.. | |
| Godo Kaisha Healthcare 5Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd.. | |
| Godo Kaisha SamuraiSubsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 2Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 3Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 4Subsidiary — Note38PDF p. 72 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 5Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 6Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 7Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 8Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 9Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 10Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 11Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 12Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 13Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 14Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 15Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 16Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 17Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Godo Kaisha Samurai 18Subsidiary — Note38PDF p. 73 | Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd.. | |
| Parkway Life Malaysia Sdn. Bhd.Subsidiary — Note38PDF p. 73 | Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Malaysia Pte. Ltd.. | |
| Parkway Life Soleil SASSubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Nova Pte. Ltd.. | |
| Parkway Life Sante SCSubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Nova Pte. Ltd.. | |
| Parkway Life Sante 1 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Parkway Life Sante 2 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Parkway Life Sante 3 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Parkway Life Sante 4 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Parkway Life Sante 5 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Parkway Life Sante 6 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Sante SC. | |
| Parkway Life Sante 7 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Sante SC. | |
| Parkway Life Sante 8 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding and special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Parkway Life Sante 9 SCISubsidiary — Note38PDF p. 73 | Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding and special purpose entity – Investment in real estate; held through Parkway Life Sante SC. | |
| Champs InvestSubsidiary — Note38PDF p. 74 | Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 6 SCI. | |
| Saint Marcel InvestSubsidiary — Note38PDF p. 74 | Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 7 SCI. | |
| Villers-Semeuse InvestSubsidiary — Note38PDF p. 74 | Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 8 SCI. | |
| SCI TurquoiseSubsidiary — Note38PDF p. 74 | Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 9 SCI. | |
| PT Tritunggal Sentra Utama SurabayaAssociate — Note39PDF p. 74 | Country: Indonesia; effective ownership and voting interest FY2025/FY2024: 30.00% / 30.00%; principal activity: Provision of medical diagnostic services; held through Gleneagles Medical Holdings Limited. | |
| Asia Renal Care Mt Elizabeth Pte. Ltd.Associate — Note39PDF p. 74 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 20.00% / 20.00%; principal activity: Provision of dialysis services and medical consultancy services; held through Gleneagles Medical Holdings Limited. | |
| Asia Renal Care (Katong) Pte. Ltd.Associate — Note39PDF p. 74 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 20.00% / 20.00%; principal activity: Provision of dialysis services and medical consultancy services; held through Gleneagles Medical Holdings Limited. | |
| Positron Tracers Pte. Ltd.Associate — Note39PDF p. 74 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 33.00% / 33.00%; principal activity: Ownership and operation of a cyclotron for production of radioactive tracers; held through Medi-Rad Associates Ltd.. | |
| RHT Health TrustAssociate — Note39PDF p. 74 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 8.67% / 8.67%; principal activity: Under members voluntary liquidation; held through Fortis Healthcare International Limited. | |
| The Lanka Hospitals Corporation PLCAssociate — Note39PDF p. 74 | Country: Sri Lanka; effective ownership and voting interest FY2025/FY2024: 8.93% / 8.93%; principal activity: Operates a multi-specialty hospital; held through Fortis Asia Healthcare Pte. Ltd.. | |
| Gleneagles JPMC Sdn. Bhd. Fortis Healthcare International Limited holds 25.14% RHT Health Trust from RHT Health Trust ManagerAssociate — Note39PDF p. 74 | Country: Brunei Darussalam shares in RHT Health Pte. Limited. RHT Heath; effective ownership and voting interest FY2025/FY2024: 30.00% / 30.00%; principal activity: Management and operation of a cardiac and cardiothoracic care centre Trust. In 2025, Fortis Asia Healthcare Pte. Ltd. acquired Trust was delisted from the Official List of the SGX-ST; held through Parkway Holdings Limited. | |
| Apollo Gleneagles PET-CT Private LimitedJoint venture — Note40PDF p. 75 | Country: India; effective ownership and voting interest FY2025/FY2024: – / 50.00%; principal activity: Disposed during the year; held through Parkway-Healthcare (Mauritius) Ltd.. | |
| Shenton Family Medical Clinic (Ang Mo Kio)Joint venture — Note40PDF p. 75 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 60.00% / 60.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd.. | |
| Shenton Family Medical Clinic (Bedok Reservoir)Joint venture — Note40PDF p. 75 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 62.50% / 62.50%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd.. | |
| Shenton Family Medical Clinic (Duxton)Joint venture — Note40PDF p. 75 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd.. | |
| Shenton Family Medical Clinic (Tampines)Joint venture — Note40PDF p. 75 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd.. | |
| Shenton Family Medical Clinic (Towner)Joint venture — Note40PDF p. 75 | Country: Singapore; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd.. | |
| Agilus Diagnostics (Nepal) Pvt. Ltd.Joint venture — Note40PDF p. 75 | Country: Nepal; effective ownership and voting interest FY2025/FY2024: 13.90% / 10.18%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited. | |
| Fortis C-Doc Healthcare LimitedJoint venture — Note40PDF p. 75 | Country: India; effective ownership and voting interest FY2025/FY2024: 18.70% / 18.70%; principal activity: Operates a hospital; held through Fortis Hospitals Limited. | |
| Fortis Cauvery (Partnership Firm)Joint venture — Note40PDF p. 75 | Country: India; effective ownership and voting interest FY2025/FY2024: 15.90% / 15.90%; principal activity: Under members voluntary liquidation; held through Fortis Cancer Care Limited. | |
| Uniglo Enterprise Sdn. Bhd. The Group has accounted for the entity as a joint the joint venture partner.Joint venture — Note40PDF p. 75 | Country: Malaysia venture in accordance with; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of an Eye Specialist Clinic MFRS on the basis that the entity’s operating decisions; held through Bedrock Healthcare Sdn. Bhd.. | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Seow Ching Voon | COMPANY SECRETARY | As at 31 March 2026 · As at 2026-03-31 | PDF p. 86 |
Extracted from IHH Healthcare Berhad Annual Report 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Sales and provision of services | 1 RM'mil | Group, with substantial shareholders (incl. parties controlled by them), 2025 | PDF p. 62 |
| Purchases and consumption of services | (26) RM'mil | Group, with substantial shareholders (incl. parties controlled by them), 2025 | PDF p. 62 |
| Sales and provision of services | 10 RM'mil | Group, with associates and joint ventures, 2025 | PDF p. 62 |
| Sales and provision of services | 11 RM'mil | Group, with key management personnel (incl. parties controlled by them), 2025 | PDF p. 62 |
| Purchases and consumption of services | (182) RM'mil | Group, with key management personnel (incl. parties controlled by them), 2025 | PDF p. 62 |
| Khazanah Nasional Berhad (KNB) | 25.85% | Related party by virtue of substantial shareholding in the Company, 2025 (2024: 25.92%) | PDF p. 61 |
| RECURRENT RELATED PARTY TRANSACTIONS | did not exceed the threshold prescribed | Group, FY2025 | PDF p. 77 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| 41. CONTINGENT LIABILITIES (a) | INR7 billion (equivalent to RM325 million) | Group, as at 31 December 2025 · As at 2025-12-31 | PDF p. 75 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Non-executive directors: − Fees | 8 RM'mil | Group, 2025 (2024: 7) | PDF p. 47 |
| Non-executive directors: − Fees | 5 RM'mil | Company, 2025 (2024: 3) | PDF p. 47 |
| Board of Directors | 825,000 RM per annum | Proposed Chairman fee, 1 July 2026 to 30 June 2027 | PDF p. 81 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Mount Elizabeth Novena Hospital | Leasehold 2108 N/A Strata Hospital 12 4,425 a | Singapore; 38 Irrawaddy Road, Singapore 329563; Leasehold land and building; hospital and medical centre units | PDF p. 80 |
| Mount Elizabeth Hospital | Leasehold 2075 N/A Strata Hospital 46 1,595 a,b | Singapore; 3 Mount Elizabeth, Singapore 228510; Leasehold land and building; hospital and medical centre units | PDF p. 80 |
| Gleneagles Hospital | Freehold – N/A Strata Hospital 34 827 a,b | Singapore; 6 Napier Road, Singapore 258499; 6A Napier Road, Singapore 258500; Freehold land and building; hospital and medical centre units | PDF p. 80 |
| Island Hospital | Leasehold 2119 44,844 Built-up Hospital 23 years for 855 c | Malaysia; No. 308, Macalister Road, 10450 George Town, Penang; Leasehold and freehold land and building | PDF p. 80 |
| Prince Court Medical Centre | Leasehold 2103 29,108 Built-up Hospital 18 678 d | Malaysia; 39 Jalan Kia Peng, 50450 Kuala Lumpur; Leasehold land and building | PDF p. 80 |
| Gleneagles Hospital Medini Johor | Leasehold 2107 80,497 Built-up Hospital 10 347 a | Malaysia; No. 2, Jalan Medini Utara 4, Medini Iskandar, 79250 Iskandar Puteri, Johor; Leasehold land and building | PDF p. 80 |
| Parkway Shanghai Hospital | Leasehold 2066 35,754 Built-up Hospital 2 326 | China; No.1172, JiLe Road, Minhang District, Shanghai; Leasehold land and building | PDF p. 81 |
| Gleneagles Hospital Hong Kong | Leasehold 2063 27,500 Built-up Hospital 8 1,702 | Hong Kong; 1 Nam Fung Path, Wong Chu Hang; Leasehold land and building | PDF p. 81 |
| Acibadem Kent Hospital | Freehold – 35,000 Built-up Hospital <1 1,027 | Türkiye; Bayrakli/Izmir; Freehold land and building | PDF p. 81 |
| Acibadem Kartal Hospital | Freehold – 4,665 Built-up Hospital <1 372 | Türkiye; Kartal-Istanbul; Freehold land and building | PDF p. 81 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| 43. SUBSEQUENT EVENT (a) | On 9 January 2026, IHL completed the acquisition of 100% equity stake in TMI Healthcare Private Limited (“THPL”) for a total | Group · As at 2026-01-09 | PDF p. 76 |
| 43. SUBSEQUENT EVENT (b) | On 20 January 2026, the shareholders of IHH approved the IHH Long-Term Incentive Plan (“LTIP”) at its extraordinary general | Company · As at 2026-01-20 | PDF p. 76 |
| 43. SUBSEQUENT EVENT (c) | On 19 February 2026, PLife REIT issued 166,139 new PLife REIT units being part payment of base fee component of the | Group · As at 2026-02-19 | PDF p. 76 |
Extracted from IHH Healthcare Berhad Annual Report 2025 and checked against the cited pages; see the original report for full context.
Corporate information